Robb Gary Charles 4
4 · CORCEPT THERAPEUTICS INC · Filed Jun 18, 2025
Insider Transaction Report
Form 4
Robb Gary Charles
Chief Business Officer
Transactions
- Sale
Common Stock
2025-06-16$70.77/sh−3,185$225,402→ 13,364 total
Holdings
- 11,571(indirect: By Children)
Common Stock
- 11,571(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]Includes 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024, 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025 and 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- [F2]These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
- [F3]These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.